eCOA/ePRO

Empowerment Model: A Model to Efficiently Build eCOA Clinical Trials

As pioneers in eSource, a technology that enables electronic data capture at its inception, we’re constantly looking for ways to streamline clinical trials and minimize the time it takes to launch them. By using our Lunexis™ eSource Ecosystem, our customers shave months off their timelines due to the near-elimination of source data verification (SDV) and the ability to access and analyze data in real time.

Read More
Kim Romanello Kim Romanello August 31, 2021

Receive Industry Updates
SUBSCRIBE TO OUR BLOG

Filter By Category

See all

Filter By Author

See all

More Articles

All posts

About Clinical Ink

Clinical Ink, a global clinical technology company, offers data certainty from source to submission via our Lunexis™ eSource clinical technology and configurable direct data capture (DDC), eCOA, ePRO, and eConsent modules. This suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source naturally enhances clinical trial workflows. For decentralized or traditional trials, Lunexis technology reduces manual labor and provides anytime, anywhere data access, saving resources as your trials progress. For more information, visit clinicalink.com.